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hts reser
y of Fore
osting by EAbstract A simple, reliable, and sensitive kinetic method for the accurate and sensitive determina-
tion of Tizanidine hydrochloride (TIZ) is described. The method is based on the alkaline oxidation
of TIZ with potassium permanganate at a ﬁxed time of 25 min. The formed manganate ion is mea-
sured at 610 nm. The concentration of TIZ is calculated using the calibration equation for the ﬁxed
time method. Beer’s law is obeyed in the range of 2–13 lg ml1, and the results are validated sta-
tistically and checked through recovery studies. This method has been successfully applied for
the determination of the studied drug in commercial dosage forms. Statistical comparisons of the
results with the reference methods show excellent agreement and indicate no signiﬁcant difference
in accuracy and precision.
ª 2011 Forensic Medicine Authority. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Tizanidine hydrochloride (TIZ) is 5-chloro-N-(4,5-dihydro-
1H-imidazol-2-yl)-2,1,3-benzothiadiazol-4-amine hydrochlo-
ride. It is a muscle relaxant and alpha2 adrenergic agonist.1il.com (M.E.M. Hassouna).
Authority. Production and
ved.
nsic Medicine Authority.
lsevierIt is used to treat the spasms,2,3 cramping, and tightness of
muscles caused by medical problems, such as multiple sclero-
sis, spastic diplegia, back pain, or certain other injuries to
the spine or central nervous system.
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Figure 1 Absorption spectra of Tizanidine hydrochloride
(5.0 lg ml1) after reaction with KMnO4: (a) oxidation product,
(b) manganate ions.
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Figure 2 Effect of time on the absorbance intensity of the
oxidation of Tizanidine hydrochloride (2.0 · 105M) with KMnO4
(1.0 · 102M), NaOH= 0.05 M, k= 610 nm.
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Figure 3 Effect of volume of KMnO4 (1.0 · 102M) on the
absorbance intensity of Tizanidine hydrochloride (2.5 · 105M),
NaOH= 0.05 M, k= 610 nm.
20 M.E.M. Hassouna et al.Several methods have been applied for the determination of
TIZ in dosage forms and in biological ﬂuids. The different
techniques published include high-performance liquid chroma-
tography (HPLC),4–6 TLC,4,6 GC7 and electrochemical.8,9
In this paper, a study of the determination of TIZ in pure
form and in different pharmaceutical preparations available
in the Egyptian market has been undertaken. The proposed
method is based on the alkaline oxidation of TIZ with potas-
sium permanganate at a ﬁxed time of 25 min.
Different factors affecting these reactions have been stud-
ied. The proposed method has the advantage of being rapid,
simple, accurate, economic, and sensitive.
2. Experimental
2.1. Apparatus
A JASCO 530 V spectrophotometer that was equipped with a
10 mm quartz cell and had a kinetic accessory equipped with a
temperature-controlled cell was used for all spectrophotomet-
ric measurements.
Comparative HPLC determinations have been carried out
by the aid of an Agilent HPLC system (Model 1200) with auto
sampler under the conditions of the standard procedure cited
in Section 2.3.3.
2.2. Materials and reagents
The following materials and reagents were used:
 Potassium permanganate (Merck, Germany); 1 · 102 M
aq. solution, freshly prepared.
 Sodium hydroxide (BDH, UK): 0.5 M aq. solution was pur-
chased fromNovartis pharma (Sawah St-Amiria-Cairo, Egypt).
 Sirdalud (4 mg), Roysan (4 mg), Tizyl (4 mg), Rekan (4 mg)
and S.M.R (2 mg) tablets containing TIZ were obtained
from commercial sources in the local market.
Standard solutions: A stock solution was prepared by dis-
solving 20.0 mg of TIZ in 100 ml of bidistilled water and fur-
ther diluted with the same solvent as appropriate.
2.3. Procedures
2.3.1. Recommended general procedure
Aliquots of 1.0 ml KMnO4 solution (1 · 102 M) and 1.0 ml
of 0.5 M NaOH solution were placed in 10 ml volumetric
ﬂasks. Accurate volumes of the working solution over the
concentration range of 2–13 lg ml1 were added, and the solu-
tions were mixed well and diluted to volume with bidistilled
water. At a ﬁxed time of 25 min, the absorbance was measured
directly at 610 nm against a reagent blank. The calibration
graph was constructed by plotting the ﬁnal concentration of
the drug against the absorbance values, measured at a ﬁxed
time of 25 min., alternatively; the corresponding regression
equation was derived.
2.3.2. Procedure for the tablets
Twenty tablets were weighed and pulverized. Weighed quantity
of the powder equivalent to 20 mg of TIZ was transferred into a
small conical ﬂask containing 3 x 30 ml of distilled water. Theresulting extract was ﬁltered into a 100 ml volumetric ﬂask.
The conical ﬂask was then washed with a fewmilliliters of bidis-
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igure 5 (A) Continuous variation plot for oxidation of
izanidine hydrochloride with KMnO4. (B) Molar ratio plot for
xidation of Tizanidine hydrochloride with KMnO4.
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Figure 4 Effect of volume of NaOH (0.5 M) on the absorbance
intensity of Tizanidine hydrochloride (2.5 · 105M), KMnO4 =
1 · 103 M, k= 610 nm.
A simple kinetic spectrophotometric method for determination of Tizanidine hydrochloride in pharmaceutical preparations 21tilled water, and the washings were poured into the same
volumetric ﬂask and complete to themarkwith the same solvent.
Aliquots covering the working concentration range were trans-
ferred into 10 ml volumetric ﬂasks.
The recommended procedure was then followed as de-
scribed in Section 2.3.1. The nominal content of the tablets
was determined by using either the calibration curve or the
corresponding regression equation.
2.3.3. Procedure for reference method18
Equal volumes (about 20 lL) of the standard preparation
and the assay preparation were separately injected into the
HPLC apparatus comprising a 230 nm detector and
4.6 mm · 15 cm column that contained packing L7; the ﬂow
rate is about 1.0 ml per minute and the column temperature
is maintained at 35 C. The relative retention times are about
0.5 for TIZ. The chromatograms were recorded, and the re-
sponses were measured for the major peaks by calculating
the quantity in mg by the formula 500c(ra/rs), where c is
the concentration in mg per mL of TIZ ra/rs peak areas ob-
tained from the assay preparation and standard preparation,
respectively.
3. Results and discussion
3.1. Optimization of the parameters
TIZ was found to react with KMnO4 in alkaline medium, pro-
ducing a bluish-green color due to the production of manga-
nate ion which absorbs maximally at 610 nm (Fig. 1).
The absorbance of the reaction product remained stable for at
least 60 min. The intensity of the color increased with time; there-
fore, a kinetically basedmethodwasdeveloped for the determina-
tion of TIZ in its pharmaceutical dosage formulations.
The different variables that affect the formation of manga-
nate ion were studied and optimized.
3.1.1. Effect of time
The intensity of the color produced increased gradually and
reached its maximum after 25 min, where it remained stable
for at least 1hr (Fig. 2).3.1.2. Effect of potassium permanganate concentration
The absorbance increased substantially with an increase in the
concentration of potassium permanganate. It was found that
1 ± 0.1 ml of 1 · 10-102 M KMnO4 was adequate for the
development of maximum absorbance (Fig. 3).
3.1.3. Effect of sodium hydroxide concentration
The inﬂuence of NaOH concentration on the reaction rate
was also studied using 0.12 ml of 0.5 M NaOH. It was found
that increasing the volume of the 0.5 M NaOH up to 1.0 ml
also increased the absorbance of the reaction product, while
further increases in volume resulted in a very slight decrease
in the absorbance. Thus, 1 ± 0.1 ml of 0.5 M NaOH was
found to be the most suitable concentration for the develop-
ment of maximum absorbance (Fig. 4). Other alkaline re-
agents with the same concentration, such as KOH and
NH4OH, were also tested to identify the best alkaline med-
ium. However, their effect on the color development was less
than that of NaOH; therefore, the latter reagent was used
throughout the study.
Oxidation of TIZ with KMnO4 was carried out in the pres-
ence of NaOH. Trials were made to determine the drugA
B
F
T
o
Table 1 Analytical parameters for the determination of
Tizanidine hydrochloride in pure form (using the ﬁxed time
method, 25 min).
Parameters Fixed time method (25 min)
Max k (nm) 610
Beer’s law limits (lg ml1) 2–13
Ringbom optimum concentration
range (lg ml1)
2.9–10
Molar absorptivity (l mol1 cm1) 1.464 · 104
Sandell sensitivity (lg cm2) 0.0198
Slope (b) 0.0505
Intercept (a) 0.00051
Correlation coeﬃcient (r) 0.99976
LOD (lg ml1) 0.27
LOQ (lg ml1) 0.90
Regression equation: A = a + bc, where c is the concentration of
Tizanidine hydrochloride (lg ml1).
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Figure 6 Absorbance versus time graphs for the reaction of
Tizanidine hydrochloride and alkaline KMnO4 at 25 C, showing
the dependence of the reaction on Tizanidine hydrochloride
concentration. Tizanidine hydrochloride concentration: (1)
1 · 105, (2) 1.5 · 105, (3) 2 · 105, (4) 2.5 · 105, (5) 3 · 105
and (6) 3.5 · 105 M, k= 610 nm.
22 M.E.M. Hassouna et al.through its oxidation with KMnO4 in neutral and acidic med-
ia, but very little oxidation of TIZ was observed under such
conditions.
3.1.4. Effect of temperature
At room temperature, the reaction rate increased substantially
with time, although the heating of the solution was found to
increase the rate of the reaction. However, MnO2 was precip-
itated at 60 C; therefore, room temperature was selected as
the optimum temperature.
3.2. Stoichiometry and reaction mechanism
Under the optimum conditions, the stoichiometry of the reac-
tion between KMnO4 and TIZ was investigated by both the
Job’s10 and molar ratio methods.11
By the application of Job’s method of continuous varia-
tions, a series of solutions were prepared by mixing equimolar
solutions of drug and KMnO4 (1 · 103 M) while keeping the
total molar concentration constant (2 · 104 M). The concen-
tration of NaOH and time of the reaction were almost con-
stant at 0.5 M and 25 min, respectively.
The plot of the absorbance of these solutions at 610 nm ver-
sus the mole fraction of the drug is presented graphically in
Fig. 5A and B. The results show that the molar ratio of
KMnO4 to TIZ was 2:1.
Based on the obtained molar reactivity and given the fact
that the oxidation of sulfur-containing compounds is smoother
and more rapid in an alkaline medium,12 the reaction pathway
is proposed to proceed as follows:  +2MnO4-
N
S
N
NH
NH
N
Cl3.3. Analytical performance
The rate of the reaction was followed at room temperature
with various concentrations of the drug in the range 2–
13 lg ml1, keeping KMnO4 and NaOH concentrations con-
stant (Fig. 6). The rate of reaction was also found to be depen-
dent on TIZ concentrations.
The reaction rate was found to obey the following equation:
Rate ¼ K0½TIZn ð1Þ
Here K0 is the pseudo-order rate constant and n is the order of
the reaction.
The rate of the reaction may be estimated by the variable-
time method13 as DA/Dt, where A is the absorbance and t is
the time in seconds.
Taking logarithms of rates and concentrations, Eq. (1) is
transformed into:
logðrateÞ ¼ logDA=Dt ¼ logK0 þ n log½TIZ ð2Þ
Regression of log (rate) versus log[TIZ] gave the regression
equation,
logðrateÞ ¼ 0:7622þ 0:908 ½TIZ ð3Þ
Hence, K0 = 5.78 s1 and the reaction is ﬁrst order (n=
0.908–1) with respect to TIZ.
3.4. Evaluation of the kinetic methods
The quantitation of TIZ under the optimized experimental
conditions outlined above would result in a pseudo-ﬁrst order
reaction with respect to its concentration. However, the rateN
S
N
NH
NH
N
Cl
O
2OH
+2MnO4  + H2O
-2
Table 3 Recovery studies of standard additions for Tizanidine hydrochloride in its pharmaceutical formulation by the proposed
kinetic method.
Pharmaceutical formulation Taken (lg ml1) Added (lg ml1) Found ± SDa Recovery ± RSD (%)
Sirdaludb 2 3 4.976 ± 0.026 99.52 ± 0.522
4 4 7.902 ± 0.0277 98.77 ± 0.35
5 7 11.916 ± 0.0492 99.30 ± 0.412
a Mean ± standard deviation of ﬁve determinations.
b Sirdalud tablets containing 4 mg of Tizanidine hydrochloride/tablet (Novartis Pharma, Sawah St-Amiria-Cairo, Egypt).
Table 2 Tests of precision of the kinetic method on the determination of pure Tizanidine hydrochloride.
Fixed time method Tizanidine hydrochloride
Taken (lg ml1) Found ± SDa (lg ml1) Recovery (%) RSDa (%) SAEb CLc
Intra-day assay 5 5.08 ± 0.082 101.64 0.377 0.0085 0.023
8 7.976 ± 0.048 99.70 0.60 0.0214 0.06
10 10.102 ± 0.017 101.02 0.168 0.0076 0.021
12 11.928 ± 0.0277 99.40 0.232 0.012 0.033
Inter-day assay 5 5.084 ± 0.0502 101.68 0.98 0.022 0.061
8 7.994 ± 0.051 99.95 0.625 0.022 0.061
10 10.088 ± 0.041 100.88 0.406 0.018 0.05
12 11.994 ± 0.0517 99.95 0.43 0.023 0.063
a Mean ± standard deviation of ﬁve determinations.
b SAE= standard analytical error.
c CL = conﬁdence limit at 95% conﬁdence level and four degrees of freedom (t= 2.776).
A simple kinetic spectrophotometric method for determination of Tizanidine hydrochloride in pharmaceutical preparations 23will be directly proportional to TIZ concentration in a pseudo-
ﬁrst order rate equation as follows:
Rate ¼ K0½TIZ ð4Þ
Several experiments were then carried out to obtain TIZ con-
centration from the rate data according to Eq. (4).
Initial rate, rate constant, ﬁxed-absorbance and ﬁxed-time
methods14,15 were tried and the most suitable analytical meth-
od was selected, taking into account the applicability, the sen-
sitivity, the intercept and the correlation coefﬁcient (r).
3.4.1. The rate constant method
A graph of log absorbance versus time for TIZ concentrations
in the range 1.0 · 105–3.5 · 105 M was plotted and all ap-
peared to be rectilinear.
Pseudo-ﬁrst order rate constants (K0) corresponding to dif-
ferent TIZ concentrations (C) were calculated from the slopes
multiplied by –2.303.
Regression of (C) versus K0 gave the following equations:
K0 ¼ 0:00119þ 27:42C ðr ¼ 0:8456Þ3.4.2. The ﬁxed concentration method
Reaction rates were recorded for different TIZ concentrations
in the same range as illustrated above. A preselected value of
the absorbance (0.2212) was ﬁxed and the time was measured
in seconds.
The reciprocal of time (1/t) versus the initial concentration
of TIZ was plotted, and the following equation of the calibra-
tion graph was obtained:
1=t ¼ 0:00859þ 617:96C ðr ¼ 0:9979Þ3.4.3. The ﬁxed-time method
Reaction rates were determined for different concentrations of
TIZ. At a pre-selected ﬁxed time, which was accurately deter-
mined, the absorbance was measured. Calibration graphs of
absorbance versus initial concentration of TIZ were estab-
lished at ﬁxed times of 5, 10, 15, 20 and 25 min.
It is clear that the slope increases with time; the most
acceptable values of the correlation coefﬁcient (r) and the
intercept were obtained for a ﬁxed time of 25 min, which
was, therefore, chosen as the most suitable time interval for
measurement (Table 1).
After optimizing the reaction conditions, the ﬁxed-time
method was applied to the determination of TIZ in pure form
over the range 2–13 lg ml1.
Analysis of the data gave the following equations:
A ¼ 0:00051þ 0:0505C ðr ¼ 0:9997Þ
where A is the absorbance at 610 nm and C is the concentra-
tion in lg ml1. Ringbom16 optimum concentration range
value is 2.9–10 lg ml1. The limit of detection (LOD) was
found to be 0.27 lg ml1 and the limit of quantiﬁcation
(LOQ) was found to be 0.90 lg ml1 (Table 1).
3.5. Accuracy and precision of the proposed method
Once the optimum conditions of the reagents to be used have
been optimized, the accuracy and precision of the ﬁxed-time
method should be established. In order to do this, four differ-
ent concentration levels (5, 8, 10 and 12 lg ml1 of pure TIZ)
were selected. The short-term precision (intra-day assay) was
determined by measuring ﬁve independent analyses at each
concentration level within one day.
Table 4 Application of the proposed kinetic method to the
determination of Tizanidine hydrochloride in its pharmaceuti-
cal formulation.
Preparation Found ± SD (%)a
Proposed method Oﬃcial method18
Sirdaludc 99.91 ± 0.40 99.96 ± 0.257
t= 1.02 (3.182)b
F= 1.84 (9.12)b
a Mean ± standard deviation of ﬁve determinations.
b The tabulated values of t- and F-tests at 95% conﬁdence limit.
c Sirdalud tablets containing 2 mg of Tizanidine hydrochloride/
tablet (Novartis Pharma, Sawah St-Amiria-Cairo, Egypt).
24 M.E.M. Hassouna et al.The daily precision (inter-day assay) was evaluated by mea-
suring the TIZ content at each level on ﬁve consecutive days by
the ﬁxed-time method. The standard deviation (SD) mean per-
cent recoveries and relative standard deviation (RSD) obtained
in intra-day and inter-day assays (Table 2) can be considered
to be satisfactory. Thus, the proposed method is effective for
the determination of TIZ in drug formulations.
3.6. Analytical recovery and interference liabilities
The accuracy of the proposed method was also checked by per-
forming recovery experiments using the standard addition
method.17 Known amounts of the pure drug were added to
TIZ tablets, and then determined by the recommended proce-
dure. The obtained mean recoveries and relative standard devi-
ations were in the range 98.77–99.52% and 0.35–0.52%,
respectively (Table 3). These results prove the accuracy of
the proposed method and absence of interference from the
common excipients.
3.6.1. Interferences
No interferences were observed in the determination of TIZ
with alkaline oxidation with potassium permanganate at a
ﬁxed time of 25 min in the presence of additives lactose, glyc-
erol, propylene glycol, sugar, sodium acetate and starch which
are usually present as ﬁllers and excipients in pharmaceutical
preparations.
3.7. Analytical applications
The ﬁxed-time method was applied for the determination of
TIZ in pharmaceutical preparations. The results obtained for
the analysis of the drug in pharmaceutical preparations (tab-
lets) compared with those obtained with the ofﬁcial method18
(Table 4).
Student’s t-test and F-test19 values of 95% conﬁdence level
did not exceed the theoretical values of 3.182 and 9.12 for the
t-test and F-test, respectively, indicating no signiﬁcant differ-
ence between the proposed method and the ofﬁcial one18 with
regard to accuracy and precision.
However, the principal advantage of the proposed method
is its suitability for routine quality control of the drug alone
and in its dosage forms without fear of interferences caused
by excipients commonly present in tablets.4. Conclusion
The kinetically based method proposed in this work for the
quantitation of TIZ is a direct and satisfactorily sensitive
method. Furthermore, it does not need the elaborate treat-
ment, tedious extraction and sophisticated apparatus required
in chromatographic methods. The data given above reveal that
the proposed method is accurate and sensitive with good pre-
cision and accuracy. With such method, one can do analysis at
low cost without losing accuracy. Also, it can be used for rou-
tine determination of TIZ in its pure form and in pharmaceu-
tical preparations.References
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